Economic burden and costs of chronic migraine

Current Pain and Headache Reports
Michel Lanteri-Minet

Abstract

Chronic migraine (CM) is a subtype of migraine broadly defined by the presence of headache at least 15 days per month. Emerging evidence suggests that CM and episodic migraine (EM) differ not only in headache frequency, but that they are distinct clinical entities. Because individuals with CM are more disabled, they demonstrate higher societal burden than those with EM. There have been three important surveys published within the last five years that have focused on the societal burden associated with CM. The first is the American Migraine Prevalence and Prevention (AMPP) study, a longitudinal population-based survey performed in the U.S. The second, the International Burden Migraine Study (IBMS), is a Web-based survey conducted in North America, Western Europe, Asia/Pacific, and Brazil. The third is a clinic-based survey performed in Taiwan. This review discusses results of these studies with regard to healthcare resource use (and related direct costs) and loss of productivity (and related indirect costs) from the perspective of cost-effectiveness of new therapeutic approaches to CM.

References

Feb 1, 1987·Headache·N T MathewF Perez
May 25, 2005·Cephalalgia : an International Journal of Headache·S D SilbersteinUNKNOWN International Headache Society
Jul 21, 2009·Cephalalgia : an International Journal of Headache·J L NatoliR B Lipton
Jan 1, 2010·Journal of Occupational and Environmental Medicine·Walter F StewartRichard B Lipton
Feb 19, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·D C BuseR B Lipton
Jul 22, 2010·Cephalalgia : an International Journal of Headache·S K AuroraUNKNOWN PREEMPT 1 Chronic Migraine Study Group
Jul 22, 2010·Cephalalgia : an International Journal of Headache·H C DienerUNKNOWN PREEMPT 2 Chronic Migraine Study Group
Nov 11, 2010·Current Pain and Headache Reports·Aubrey N ManackRichard B Lipton
Jun 22, 2011·Cephalalgia : an International Journal of Headache·Krista A PayneAndrew M Blumenfeld
Nov 16, 2011·Current Pain and Headache Reports·Zaza KatsaravaRichard B Lipton
Feb 26, 2013·Headache·Kathleen R Merikangas
Mar 14, 2013·Cephalalgia : an International Journal of Headache·Dawn C Buse, Richard B Lipton
Jun 19, 2013·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification Committee of the International Headache Society (IHS)
Jun 13, 2014·Cephalalgia : an International Journal of Headache·Jes Olesen

❮ Previous
Next ❯

Citations

Oct 11, 2014·Pharmacogenomics·Giovanna GentileMarina Borro
Aug 25, 2015·British Journal of Clinical Pharmacology·R Allan JhagrooKristina L Penniston
Nov 18, 2014·Annals of the New York Academy of Sciences·Scott M WhitcupMitchell F Brin
May 23, 2015·Headache·Brinder VijAnn Vincent
Jan 31, 2017·The Journal of Headache and Pain·Ettore Beghi
Feb 24, 2018·Clinical Neuropharmacology·Regina R BerkovichSoma Sahai-Srivastava
Oct 21, 2017·Expert Opinion on Investigational Drugs·Anna FerrariCarlo Baraldi
Nov 9, 2017·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Hsiangkuo YuanStephen D Silberstein
Jul 26, 2018·Journal of Managed Care & Specialty Pharmacy·Janet H FordSheena K Aurora
Feb 20, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·M V NaprienkoL I Baiushkina
May 21, 2019·Cephalalgia : an International Journal of Headache·Dustin D RuffSheena K Aurora
Dec 24, 2015·Current Pain and Headache Reports·Soo-Jin ChoMin Kyung Chu
Sep 25, 2019·Headache·Rebecca Wig, Christopher B Oakley
Oct 23, 2019·Pharmacogenomics·Marina BorroGiovanna Gentile
May 21, 2016·The Nurse Practitioner·Maureen Moriarty, Theresa Mallick-Searle
Jan 15, 2015·Expert Review of Neurotherapeutics·Giovanna GentileMarina Borro
Apr 21, 2017·Turkish Journal of Medical Sciences·Gonca MumcuRafi Haner Direskeneli
Apr 10, 2019·Chiropractic & Manual Therapies·Jim OdellJonathan Branney
Jul 29, 2019·Journal of Medical Systems·Can ChenHongru Zhao
Sep 20, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Mansoureh ToghaRajabali Daroudi
Oct 21, 2020·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Carrie R HoutsRichard B Lipton
Feb 7, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Maria Michela CainazzoSimona Guerzoni
Dec 11, 2020·Neurology. Clinical Practice·Virginia Baker, Nawaz Hack
Mar 5, 2021·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Alicia Gonzalez-MartinezAna Beatriz Gago-Veiga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.